top of page
Recent advances in our understanding of prostate cancer genetics have transformed the field. Researchers talk about abnormal genes (BRACA 1,2) and the use of genetics for treatment decisions (Precision medicine) and applications for Active Surveillance.
22-10. K. Wiedemer, C. Chan "Your Genes, Prostate Cancer, and the PROMISE Registry" 2022-10-27
22-08. Jason Alter, Ph.D "Liquid Test for Prostate Biopsy Decision Making" 2022-08-25
22-09. Dr. Roisin Puentes "Liquid Biopsy and Biomarker Testing in Prostate Cancer" 2022-09-22
21-03. Dr Richard Lam "The Role of Genetic Testing in Prostate Cancer" March 25, 2021
bottom of page